Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NBP270697FR

Factor XIIIb Antibody (OTI1A3), DyLight 680, Novus Biologicals™
SDP

Catalog No. NBP270697FR Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NBP270697FR 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NBP270697FR Supplier Novus Biologicals Supplier No. NBP270697FR

Description

Mouse Monoclonal Antibody

Factor XIIIb Monoclonal specifically detects Factor XIIIb in Human samples. It is validated for Western Blot.

Specifications

Antigen Factor XIIIb
Applications Western Blot
Classification Monoclonal
Clone OTI1A3
Conjugate DyLight 680
Dilution Western Blot
Formulation PBS with 0.05% Sodium Azide
Gene Alias coagulation factor XIII B chain, coagulation factor XIII, B polypeptide, F13B, fibrin-stabilizing factor B subunit, FXIIIB, protein-glutamine gamma-glutamyltransferase B chain, TGase, transglutaminase B chain
Gene Symbols F13B
Host Species Mouse
Immunogen Recombinant protein fragment corresponding to amino acids 357-661 of human Factor XIII (NP_001985) produced in E.coli.
Purification Method Affinity Purified
Quantity 0.1 mL
Primary or Secondary Primary
Gene ID (Entrez) 2165.0
Target Species Human
Content And Storage Store at 4°C in the dark.
Isotype IgG1
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.